Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fangfei Niu"'
Autor:
Lusong Tian, Zongpan Jing, Xiufeng Xie, Peng Nan, Jiajia Gao, Jun Li, Yan Sun, Xiaohang Zhao, Ying Zhu, Fang Liu, Fangfei Niu, Yan Zhao, Lanping Zhou, Yulin Sun
Publikováno v:
Cancer Letters. 519:46-62
Sorafenib and lenvatinib are approved first-line targeted therapies for advanced liver cancer, but most patients develop acquired resistance. Herein, we found that sorafenib induced extensive acetylation changes towards a more energetic metabolic phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba60fa3b95c04c02b3f39028ef7265e3
https://doi.org/10.1016/j.canlet.2021.06.016
https://doi.org/10.1016/j.canlet.2021.06.016
Autor:
Liping Yang, Jia Yao, Caiyan Kou, Shurong Qin, Huan Xu, Ruiping Huang, Jinhui Tian, Huaping Wei, Yanxian Ren, Yanyan Lin, Yu Ren, Fangfei Niu, Jinying Cao, Xianzhuo Zhang, Haiping Wang, Wenbo Meng
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6d1d488c11001cfce42e7584fede1a3
https://doi.org/10.2139/ssrn.4267528
https://doi.org/10.2139/ssrn.4267528
Autor:
Zong-Yong Wu, Gaijing Han, Lanping Zhou, Xiaohang Zhao, Fangfei Niu, Nan Zhao, Yang Xu, Fang Liu
Publikováno v:
Oncotarget
// Gaijing Han 1, * , Zongyong Wu 2, * , Nan Zhao 1 , Lanping Zhou 1 , Fang Liu 1 , Fangfei Niu 1 , Yang Xu 1 and Xiaohang Zhao 1 1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793b8b742377672f7065fa413fb229e0
http://europepmc.org/articles/PMC5617461
http://europepmc.org/articles/PMC5617461
Publikováno v:
Cancer Medicine
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal cancer in humans, with a 5‐year survival rate of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244cf51b12aee0db8d66865c802f9a9b
https://doi.org/10.1002/cam4.1064
https://doi.org/10.1002/cam4.1064
Autor:
Gaijing Han, Lu Yan, Lianqi Sun, Liu Yonghua, Zongpan Jing, Fangfei Niu, Xiaohang Zhao, Yanbin Wu, Yang Xu, Laixing Hu, Lanping Zhou
Publikováno v:
Cancer letters. 420
Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide due to its chemoresistance and poor prognosis. Currently, there is a lack of effective small molecule drugs for the treatment of ESCC. Microtubules are an attractiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f91b5a874480cf199835c876c264a30
https://pubmed.ncbi.nlm.nih.gov/29408653
https://pubmed.ncbi.nlm.nih.gov/29408653
Autor:
Yuan Yuan, Fangfei Niu, Binghua Wu, Meiling Lyu, Peining Wei, Hongliang Zhang, Xiaofeng Liu, Panpan Wang
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 16, p 4001 (2019)
Volume 20
Issue 16
International Journal of Molecular Sciences, Vol 20, Iss 16, p 4001 (2019)
Volume 20
Issue 16
Sugar transporters of the SWEET family mediate cross membrane movement of mono- and disaccharides and play vital roles in diverse physiological and pathophysiological processes, including sink&ndash
source relationship, pathogen responses, repro
source relationship, pathogen responses, repro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce59a245f0051df24cb6252645eb80b
https://doi.org/10.3390/ijms20164001
https://doi.org/10.3390/ijms20164001